IV Aminoglycosides

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 17
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2016-03-31T01:00:12-04:00",
  "meta" : {
    "versionId" : "38",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "Lantana EH Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This set of values includes select antibiotics that are used in an inpatient setting for surgical prophylaxis.  These antibiotics are Aminoglycosides only.  These are not dose specific, however, they must only be given intravenously.),(Data Element Scope: The intent of this data element is to identify patients who are on prophylactic antibiotics prior to surgery consistent with current guidelines.  Using the Quality Data Model, this element will map to the Medication category.),(Inclusion Criteria: Only use codes which represent Aminoglycoside antibiotics which are given intravenously.  Codes used are to be RxNorm codes only.),(Exclusion Criteria: None)",
  "name" : "IVAminoglycosides",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1723156",
      "display" : "2 ML amikacin 250 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1723160",
      "display" : "4 ML amikacin 250 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "197736",
      "display" : "50 ML gentamicin 2 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "239204",
      "display" : "gentamicin 10 MG/ML Injectable Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "242816",
      "display" : "100 ML gentamicin 1 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "242825",
      "display" : "50 ML tobramycin 1.2 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "310473",
      "display" : "100 ML gentamicin 0.8 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "310474",
      "display" : "100 ML gentamicin 0.9 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "310476",
      "display" : "50 ML gentamicin 1.4 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "310477",
      "display" : "50 ML gentamicin 1.6 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "313416",
      "display" : "tobramycin 10 MG/ML Injectable Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "313996",
      "display" : "gentamicin 40 MG/ML Injectable Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "597823",
      "display" : "tobramycin 40 MG/ML Injectable Solution",
      "version" : "05062024"
    } ],
    "total" : 13,
    "identifier" : "urn:uuid:8659f460-6ee1-40aa-88a0-aaaae990288d",
    "timestamp" : "2024-06-14T18:02:17-04:00"
  },
  "title" : "IV Aminoglycosides",
  "extension" : [ {
    "valueString" : "Lantana EH Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-06-03",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2016-03-31",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "retired",
  "id" : "2.16.840.1.113883.3.666.5.727",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.727",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.666.5.727"
  } ],
  "version" : "20160331"
}